Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells-Reference-Cited by-同舟云学术

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells

Published:2017-09-01 Issue:53 Volume:8 Page:91803-91816
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Opyrchal Mateusz¹,Gil Malgorzata¹,Salisbury Jeffrey L.²,Goetz Mathew P.³,Suman Vera³,Degnim Amy³,McCubrey James⁴,Haddad Tufia³,Iankov Ianko³,Kurokawa Chenye B.⁵,Shumacher Nicole²,Ingle James N.³,Galanis Evanthia³⁵,D’Assoro Antonino B.³²

Affiliation:

1. Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA

2. Department of Biochemistry and Molecular Biology, Mayo Clinic College Of Medicine, Rochester, MN, USA

3. Department of Medical Oncology, Mayo Clinic College Of Medicine, Rochester, MN, USA

4. Department of Microbiology and Immunology, East Carolina University, Greenville, NC, USA

5. Department of Molecular Medicine, Mayo Clinic College Of Medicine, Rochester, MN, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer;Frontiers in Oncology;2024-05-30

2. Emerging roles of Aurora-A kinase in cancer therapy resistance;Acta Pharmaceutica Sinica B;2023-07

3. Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells;International Journal of Molecular Sciences;2022-11-14

4. Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2022-09-02

5. A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer;Cancers;2022-07-01